Researcher
Geert Leroux-Roels
- Keywords:applied immunology, influenza, Vaccinology
- Disciplines:Infectious diseases, Vaccinology, Virology, Applied immunology
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Clinical chemistry, microbiology and immunology (Department)
Responsible
From1 Oct 2013 → 30 Sep 2017 - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Oct 2013 → 30 Sep 2017 - Board of Governors/Executive Board (Administrative office)
Member
From1 Oct 2008 → 30 Sep 2014 - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Oct 1997 → 30 Sep 2018
Projects
1 - 2 of 2
- BIOVACSAFE – Biomarkers for enhanced vaccine safetyFrom1 Mar 2012 → 31 Aug 2018Funding: Other EU initiatives out of framework
- Transmission fo the hepatitis C virus: from understanding the mechanisms to clinical applicationsFrom1 Jan 2012 → 31 Oct 2018Funding: BOF - Concerted Research Project from 1994
Publications
21 - 30 of 89
- Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants : a comparative, observer-blind, randomised, controlled trial(2016)
Authors: Xavier Saez-Llorens, Ralf Clemens, Geert Leroux-Roels, Jose Jimeno, Sue Ann Costa Clemens, William C Weldon, M Steven Oberste, Natanael Molina, Ananda S Bandyopadhyay
Pages: 321 - 330 - Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults : a phase 3, randomized trial and post-hoc correlate of protection analysis(2016)
Authors: Guillermo M Ruiz-Palacios, Geert Leroux-Roels, Jiri Beran, Jeanne-Marie Devaster, Meral Esen, Odile Launay, Janet E McElhaney, Gerrit A van Essen, Anne Benoit, Carine Claeys, et al.
Pages: 3043 - 3055 - Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine : results from a phase II, randomized, multicenter trial(2016)
Authors: Geert Leroux-Roels, Arnaud Marchant, Jack Levy, Pierre Van Damme, Tino F Schwarz, Yves Horsmans, Wolfgang Jilg, Peter G Kremsner, Edwige Haelterman, Frédéric Clement, et al.
Pages: 16 - 27 - Old and new adjuvants for hepatitis B vaccines(2015)
Authors: Geert Leroux-Roels
Pages: 69 - 78 - Human liver chimeric mice as a novel model for the study of hepatitis E virus infections(2015)Volume: 22
Authors: Ibrahim Mahmoud Sayed Ibrahim, Lieven Verhoye, Y Debing, F Abbravanel, Aliasghar Farhoudi Moghadam, Geert Leroux-Roels, J Neyts, J Izopet, R Purcell, S Emerson, et al.
Pages: 13 - 13 - Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials(2015)
Authors: Isabel Leroux-Roels, Jeanne-Marie Devaster, Geert Leroux-Roels, Vincent Verlant, Isabelle Henckaerts, Philippe Moris, Philippe Hermand, Pascale Van Belle, Jan T Poolman, Pierre Vandepapeliére, et al.
Pages: 577 - 584 - A broadly neutralizing monoclonal antibody targeting hepatitis C virus prevents viral infection in vitro and in uPA/SCID mice with humanized liver(2015)
Authors: Ahmed Atef Ahmed Abouzeid Mesalam, Isabelle Desombere, Richard Urbanowicz, Daniel X Johansson, Aliasghar Farhoudi Moghadam, Freya Van Houtte, Lieven Verhoye, Mats Persson, Jonathan Ball, Geert Leroux-Roels, et al.
Number of pages: 1 - Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age(2015)
Authors: Markus Knuf, Geert Leroux-Roels, Hans. C Ramke, Katia Abarca, Luis Rivera, Maria Lattanzi, Paola Pedotti, Ashwani Arora, Dorothee Kieninger-Baum, Giovanni Della Cioppa
Pages: 174 - 181 - Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination(2015)
Authors: Geert Leroux-Roels, Pascale Van Belle, Pierre Vandepapeliere, Yves Horsmans, Michel Janssens, Isabelle Carletti, Nathalie Garçon, Martine Wettendorff, Marcelle Van Mechelen
Pages: 1084 - 1091 - Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice(2015)Volume: 62
Authors: Koen Vercauteren, Richard JP Brown, Ahmed Atef Ahmed Abouzeid Mesalam, Juliane Doerrbecker, Sabin Bhuju, Robert Geffers, Naomi Van den Eede, Fulvia Troise, Lieven Verhoye, Thomas Baumert, et al.
Pages: S214 - S214